ERG Antibody | 45-549

ERG Antibody | 45-549 | Gentaur UK, US & Europe Distribution

Host: Goat

Reactivity: Human

Homology: Expected Species Reactivity based on sequence homology: Mouse, Rat

Immunogen: The immunogen for this antibody is: C-PNTRLPTSHMPSH

Research Area: Cancer

Tested Application: E, WB

Application: Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:Approx 55kDa band observed in lysates of cell line MOLT4 (calculated MW of 53.8kDa according to NP_891548.1) . Recommended concentration: 0.1-0.3ug/ml. Primary incubation was 1 hour.

Specificiy: This antibody is expected to recognise all reported isoforms (NP_891548.1; NP_004440.1; NP_001129626.1; NP_001129627.1; NP_001230358.1)

Positive Control 1: Cat. No. 1312 - Human Prostate Tissue Lysate

Positive Control 2: Cat. No. 10-101 - Human Prostate Tissue Slide

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.

Concentration: 500 ug/mL

Storage Condition: Aliquot and store at -20˚C. Minimize freezing and thawing.

Alternate Name: ERG, v-ets erythroblastosis virus E26 oncogene like (avian) , HGNC:3446, erg-3, p55, transcriptional regulator ERG (transforming protein ERG) , v-ets avian erythroblastosis virus E26 oncogene related, v-ets erythroblastosis virus E26 oncogene like, v-ets erythroblastosis virus E26 oncogene homolog (avian) , OTTHUMP00000115970, OTTHUMP00000208036, TMPRSS2-ERG prostate cancer specific, ets-related

User Note: N/A

BACKGROUND: N/A